Overview of Dr. Beltran
Dr. Himisha Beltran is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, Dana-Farber Cancer Institute, and Brigham and Women's Hospital. She received her medical degree from New York Medical College and has been in practice 18 years. She is one of 455 doctors at Dana-Farber Cancer Institute and one of 377 doctors at Brigham and Women's Hospital who specialize in Oncology. She has more than 100 publications and over 500 citings.
Office
520 East 70th Street
Starr Pavilion, 3rd Floor
New York, NY 10021
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2008 - 2011
University of Pennsylvania Health SystemResidency, Internal Medicine, 2004 - 2007
New York Medical CollegeClass of 2004
Certifications & Licensure
MA State Medical License 2019 - 2025
NH State Medical License 2024 - 2024
NY State Medical License 2008 - 2019
PA State Medical License 2007 - 2008- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study in Patients With Advanced Cancers Associated With Expression of DLL3 Start of enrollment: 2020 Dec 29
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now.Neal Shore, Sarah M Nielsen, Edward D Esplin, Emmanuel S Antonarakis, Pedro C Barata
JCO Oncology Practice. 2024-12-19 - Clinical Implementation of Minimal Residual Disease Testing in Genitourinary Cancers: Bridging Promise and Practice.Rana R McKay, Joshua Lang, Himisha Beltran
European Urology. 2024-12-13 - AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients.Todd P Knutson, Bin Luo, Anna Kobilka, Jacqueline Lyman, Siyuan Guo
Nature Communications. 2024-12-11
Journal Articles
- Activity of Platinum-Based Chemotherapy in Patients with Advanced Prostate Cancer with and Without DNA Repair Gene AberrationsHimisha Beltran, Che-Kai Tsao, Tomasz M Beer, JAMA Network Open
Press Mentions
The Challenge of Finding New Tools to Fight Prostate CancerSeptember 9th, 2021- BET Inhibitors Show Promise in Overcoming Lineage Plasticity, a Newly Recognized Form of Resistance to Prostate Cancer DrugsJune 18th, 2021
- Dana-Farber Cancer Institute, a Pioneer in Cancer Care and Research, Joins Caris' Precision Oncology AllianceFebruary 16th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
